Pfizer Inc. (PFE)
NYSE: PFE
· Real-Time Price · USD
24.41
-0.11 (-0.45%)
At close: Oct 15, 2025, 3:59 PM
24.42
0.06%
Pre-market: Oct 16, 2025, 04:56 AM EDT
-0.45% (1D)
Bid | 24.38 |
Market Cap | 138.76B |
Revenue (ttm) | 63.83B |
Net Income (ttm) | 10.75B |
EPS (ttm) | 1.89 |
PE Ratio (ttm) | 12.91 |
Forward PE | 7.81 |
Analyst | Hold |
Dividends | $2.14 |
Ask | 24.4 |
Volume | 44,087,020 |
Avg. Volume (20D) | 49,117,490 |
Open | 24.49 |
Previous Close | 24.52 |
Day's Range | 24.21 - 24.58 |
52-Week Range | 20.92 - 29.82 |
Beta | 0.47 |
Ex-Dividend Date | Nov 7, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for PFE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsPfizer Inc. is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+6.79%
Pfizer shares are trading higher after President T...
Unlock content with
Pro Subscription
2 weeks ago
+6.83%
Pfizer shares are trading higher after The Washington Post reported President Trump will announce a drug-pricing deal with the company.

3 days ago · proactiveinvestors.co.uk
IP Group shares climb 9% on potential royalties from Pfizer's $7.3bn Metsera dealShares in IP Group PLC (LSE:IPO) rose 9% on Monday after investors welcomed the potential for future royalty income from Metsera, a biotech company that Pfizer has agreed to acquire for up to $7.3 bil...